Hide Board Information

Show Board Information

Alliance Pharma Cp ALLP

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/08/2014 6:35:37 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Alliance Pharma Cp (OTCMRKTS: ALLP) Stock Message Board

1. ALLP Company Profile

    

2. ALLP Time & Sales

    

3. ALLP Recent News

    

4. ALLP Filings

    

5. ALLP Financials

    

6. ALLP Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	Latest Alliance Pharma Cp (ALLP) Headlines	Stock_Tracker	03/08/2014 6:35:37 PM
4	ALLP 3.46 Stock Charts $ALLP 1 Month Chart	chartguy89	03/05/2014 8:52:44 PM
3	ALLP Recent News Panetta Statement on Passing of	Stock_Tracker	03/02/2014 11:31:43 AM
2	ALLP Stock Charts Saturday, February 22, 2014 at	chartguy89	02/22/2014 7:30:55 AM
1	ALLP Stock Chart N/A Saturday, February 8, 2014	chartguy89	02/08/2014 3:50:56 AM

Recent Articles

• J&T Express Sees Significant Growth in Parcel Volume for Q3
• Celebrating the Inspirational Journey of Brenna Teerlinck
• Paladin Energy's Inspiring Progress and Quarterly Insights
• Harnessing the Power of KKR: A Five-Year Investment Journey
• Electric Pickup Truck Market Grows Despite Tesla's Struggles
• Goldman Sachs Group Stock Analysis: Key P/E Ratio Insights
• Navigating the Legal Landscape of PubMatic, Inc. Shareholder Rights
• Insight into Paladin Energy's Latest Quarterly Performance
• A. O. Smith Boosts Dividend to $0.36, Spirit of Growth Alive
• Bespin Global Unveils AccelVeo for Smarter Manufacturing Operations
• NABR's Response to IUCN's Continued Endangered Status for LTM Monkeys
• The Bahamas Fiscal Success: A New Era of Economic Stability
• Young Blood Donor Honored in National Blood Donation Hall of Fame
• Copa Holdings Shares September 2025 Traffic Performance Insights
• KPC Health Welcomes Dr. Jeffrey Farkas as Neuroscience Director
• How Much Would Your $1000 Investment in Paycom Be Worth Today?
• TETRA Technologies Plans Q3 2025 Earnings Call and Webcast
• Willis Lease Finance Unveils State-of-the-Art Hangars in the UK
• Insights into Mergers and Shareholder Rights for 2025
• Class Action Alert: Shareholders Encourage Action on M&A Votes
• Strategic Insights Into d'Amico International Shipping's Market Moves
• Exploring the 5-Year Journey of American Express Stock Growth
• Investors Prepare for Possible Securities Fraud Case Against KinderCare
• Transforming Healthcare: The Role of Specialdocs in Physician Well-being
• Resolution Copper's Generous Donation Aids Globe-Miami Recovery
• Hycroft Mining Expands Offering with Underwriters' Option
• Growth Opportunities in the Allergic Rhino-Conjunctivitis Market
• RCI Hospitality Action: Investors Urged to Join Class Lawsuit
• Dalfen Industrial Expands with Strategic Property Acquisitions
• KBR, Inc. Investors: Important Class Action Deadline Approaches
• Exploring U.S. Bancorp's Stock Valuation and Market Trends
• Discover the Journey of a $100 Investment in AbbVie Stock
• How Your $100 Investment in MACOM Technology Grew Over a Decade
• Navitas Semiconductor (NASDAQ: NVTS) Soars on Market Updates
• Nutex Health Inc. Investors Urged to Join Important Class Action
• Investors Anticipate Earnings Report from America Movil
• Savara Inc. Investors: Join the Securities Class Action Today
• TAO Synergies Inc. Completes Major $11 Million Financing Deal
• Empowering Young Innovators with Dance-Integrated STEM Clubs
• Waupaca Foundry Revamps Sales Strategies for Greater Growth
• Taylor Swift Breaks Records With 'The Life of a Showgirl'
• Desert Financial's Commitment to Empower Latino Families and Leaders
• Openmarkets Group Partners with Eventus for Trade Surveillance
• Group 1 Automotive Announces Q3 2025 Financial Report Date
• Investors Explore Fraud Investigation Options for Fluor Corp
• Edelson Lechtzin Investigates SimonMed Imaging Data Breach
• Snap Inc. (SNAP) Investors Urged to Take Action Amid Lawsuit
• Polaris Inc's Strategic Move Offers Promising Futures Ahead
• Understanding the Long-Term Success of Applied Materials Stock
• Unicycive Therapeutics Faces Class Action Over Stock Statements